Status:
UNKNOWN
Amplitude-integrated EEG in Improvement of Seizure Detection and Prognostication in Children With TBI
Lead Sponsor:
Genevieve Du Pont-Thibodeau
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
Up to 18 years
Brief Summary
The goal of this study is to determine whether the addition of aEEG to cEEG in clinical practice does in fact help PICU physicians detect subclinical seizures in this population.
Detailed Description
Children with moderate to severe TBI are at risk of significant long-term neurological sequelae. Careful post-injury management is crucial in optimizing their recovery. Seizures are a frequent complic...
Eligibility Criteria
Inclusion
- moderate to severe TBI defined by a post-resuscitation Glasgow Coma Scale (GCS) of 3-8 (severe) or 9-12 (moderate), this includes those with accidental TBI, abusive head trauma, and cases of polytrauma
- decision by the primary medical team to initiate cEEG monitoring
Exclusion
- patients for whom it is impossible to record cEEG for any reason will be excluded from the study
- premature neonates
- brain death or suspected brain death at PICU entry
- unavailable equipment for cEGG and/or aEEG
- consent to participate denied by parents and/or patient
Key Trial Info
Start Date :
February 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03343964
Start Date
February 5 2018
End Date
February 1 2020
Last Update
March 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5